By Professor Liam Bourke, Sheffield Hallam University There are lots of reasons for this. The subject matter is complex. Capturing and recording prospective data in… Read More »Generating good evidence for new cancer treatments is seriously tough.
By Robert Music, Chief Executive, Jo’s Cervical Cancer Trust Of the five million women invited every year for cervical screening in the UK, over one… Read More »Computer says “no”
The HPV virus causes most cases of cervical cancer. This is why an HPV vaccination programme for girls aged 12 to 13 started in 2008.… Read More »Rates of cervical cancer in women aged 20-24 in England seen to double – should we be worried?
I’m sure there will be many obituaries over the coming days, and if you want a synopsis of Professor Altman’s accomplishments you can read his… Read More »Doug Altman – A Giant Among Statisticians
On 25th of May 2018 the EU General Data Protection Regulation (GDPR) went live. GDPR is designed to protect EU citizens from organisations using their data… Read More »Data protection versus health protection
The clinical director of the Irish national cervical screening programme Ireland, Dr Grainne Flannelly, resigned at the end of April. It was revealed that she… Read More »To tell or not to tell – what should we do?
A woman in the Republic of Ireland, Vicky Phelan, recently settled with a laboratory in America receiving $2.5million compensation for them missing abnormalities on her… Read More »Is it safe to export cancer screening?
The Secretary of State for Health, Jeremy Hunt, announced in the House of Commons that 450,00 women missed out on breast cancer screening invitations due to an… Read More »The breast screening scandal: Part 1 – why did it happen?
A group of doctors and health experts wrote to The Times urging women aged 70-79 who did not undergo routine breast cancer screening because of… Read More »The breast screening scandal: Part 2 – should women accept catch-up invitations?
